{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:53:23Z","timestamp":1781690003061,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s43440-026-00850-w","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:04:44Z","timestamp":1774353884000},"page":"731-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabidiol (CBD) modulates the serotonin\u2013kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats"],"prefix":"10.1007","volume":"78","author":[{"given":"Sofia","family":"Nasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leora","family":"Pearl-Dowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Lopez-Canul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Posa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bertazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5686-7194","authenticated-orcid":false,"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"10","key":"850_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanp\u00e4\u00e4 M, Kalso E, Loeser JD, Rice ASC, et al. A new definition of neuropathic pain. PAIN. 2011;152(10):2204\u201305.","journal-title":"PAIN"},{"issue":"10","key":"850_CR2","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1097\/j.pain.0000000000000277","volume":"156","author":"SK Momi","year":"2015","unstructured":"Momi SK, Fabiane SM, Lachance G, Livshits G, Williams FMK. Neuropathic pain as part of chronic widespread pain: environmental and genetic influences. PAIN. 2015;156(10):2100\u201306.","journal-title":"PAIN"},{"issue":"3","key":"850_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","volume":"136","author":"D Bouhassira","year":"2008","unstructured":"Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380\u201387.","journal-title":"Pain"},{"issue":"1\u20132","key":"850_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.pain.2004.04.034","volume":"110","author":"PV Rasmussen","year":"2004","unstructured":"Rasmussen PV, Sindrup SH, Jensen TS, Bach FW. Symptoms and signs in patients with suspected neuropathic pain. Pain. 2004;110(1\u20132):461\u201369.","journal-title":"Pain"},{"issue":"2","key":"850_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0301-0082(99)00051-9","volume":"61","author":"JF Herrero","year":"2000","unstructured":"Herrero JF, Laird JM, L\u00f3pez-Garc\u00eda JA. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol. 2000;61(2):169\u2013203.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"850_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0304-3959(90)91158-F","volume":"42","author":"F Boureau","year":"1990","unstructured":"Boureau F, Doubrere JF, Luu M. Study of verbal description in neuropathic pain. Pain. 1990;42(2):145\u201352.","journal-title":"Pain"},{"key":"850_CR7","unstructured":"Melzack R, Katz J. The McGill pain questionnaire: appraisal and current status. In: Handbook of pain assessment. 2nd. New York, NY, US: The Guilford Press; 2001. p. 35\u201352."},{"key":"850_CR8","doi-asserted-by":"crossref","unstructured":"Cruccu G, Truini A. A review of neuropathic pain: from guidelines to clinical practice. Pain and therapy. 2017. 6(Suppl 1):35\u201342.","DOI":"10.1007\/s40122-017-0087-0"},{"key":"850_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejphar.2018.07.038","volume":"834","author":"IK Martikainen","year":"2018","unstructured":"Martikainen IK, Hagelberg N, J\u00e4\u00e4skel\u00e4inen SK, Hietala J, Pertovaara A. Dopaminergic and serotonergic mechanisms in the modulation of pain: in vivo studies in human brain. Eur J Pharmacol. 2018;834:337\u201345.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"850_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/bjp.2008.100","volume":"154","author":"M Christie","year":"2008","unstructured":"Christie M. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154(2):384\u201396.","journal-title":"Br J Pharmacol"},{"key":"850_CR11","doi-asserted-by":"crossref","unstructured":"Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci. 2020;21(22).","DOI":"10.3390\/ijms21228870"},{"issue":"3","key":"850_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"S Deiana","year":"2012","unstructured":"Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacol (Berl). 2012;219(3):859\u201373.","journal-title":"Psychopharmacol (Berl)"},{"key":"850_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.acc.2019.08.005","volume":"95","author":"S Comai","year":"2020","unstructured":"Comai S, Bertazzo A, Brughera M, Crotti S. Tryptophan in health and disease. Adv Clin Chem. 2020;95:165\u2013218.","journal-title":"Adv Clin Chem"},{"key":"850_CR14","doi-asserted-by":"crossref","unstructured":"Zador F, Joca S, Nagy-Grocz G, Dvoracsko S, Szucs E, Tomboly C, et al. Pro-inflammatory cytokines: potential links between the Endocannabinoid System and the kynurenine pathway in depression. Int J Mol Sci. 2021;22(11).","DOI":"10.3390\/ijms22115903"},{"issue":"1","key":"850_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02700623","volume":"35","author":"K Nakamura","year":"2007","unstructured":"Nakamura K, Hasegawa H. Developmental role of tryptophan hydroxylase in the nervous system. Mol Neurobiol. 2007;35(1):45\u201353.","journal-title":"Mol Neurobiol"},{"issue":"1\u20132","key":"850_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.12.004","volume":"207","author":"M Jenny","year":"2009","unstructured":"Jenny M, Santer E, Pirich E, Schennach H, Fuchs D. Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro. J Neuroimmunol. 2009;207(1\u20132):75\u201382.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"850_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/can.2020.0105","volume":"6","author":"FR Henshaw","year":"2021","unstructured":"Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The effects of cannabinoids on Pro- and anti-inflammatory Cytokines: a systematic review of in vivo studies. Cannabis Cannabinoid Res. 2021;6(3):177\u201395.","journal-title":"Cannabis Cannabinoid Res"},{"key":"850_CR18","doi-asserted-by":"crossref","unstructured":"Auyeung A, Wang HC, Aravagiri K, Knezevic NN. Kynurenine pathway metabolites as potential biomarkers in chronic pain. Pharmaceuticals (Basel). 2023;16(5).","DOI":"10.3390\/ph16050681"},{"key":"850_CR19","doi-asserted-by":"crossref","unstructured":"Jovanovic F, Candido KD, Knezevic NN. The role of the kynurenine signaling pathway in different chronic pain conditions and potential use of therapeutic agents. Int J Mol Sci. 2020;21(17).","DOI":"10.3390\/ijms21176045"},{"key":"850_CR20","doi-asserted-by":"crossref","unstructured":"de Almeida DL, Devi LA. Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect. 2020;8(6):e00682.","DOI":"10.1002\/prp2.682"},{"issue":"2","key":"850_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","volume":"87","author":"I Decosterd","year":"2000","unstructured":"Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000;87(2):149\u201358.","journal-title":"Pain"},{"issue":"1\u20133","key":"850_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","volume":"556","author":"B Costa","year":"2007","unstructured":"Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol. 2007;556(1\u20133):75\u201383.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"850_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109\u201310.","journal-title":"Pain"},{"issue":"6","key":"850_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/bph.15977","volume":"180","author":"A Inserra","year":"2023","unstructured":"Inserra A, Giorgini G, Lacroix S, Bertazzo A, Choo J, Markopolous A, et al. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome. Br J Pharmacol. 2023;180(6):721\u201339.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"850_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","volume":"160","author":"D De Gregorio","year":"2019","unstructured":"De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. 2019;160(1):136\u201350.","journal-title":"Pain"},{"issue":"1","key":"850_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55\u201363.","journal-title":"J Neurosci Methods"},{"key":"850_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","volume":"20","author":"WJ Dixon","year":"1980","unstructured":"Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 1980;20:441\u201362.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"850_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.j.pain.0000460311.71572.5f","volume":"156","author":"M Lopez-Canul","year":"2015","unstructured":"Lopez-Canul M, Palazzo E, Dominguez-Lopez S, Luongo L, Lacoste B, Comai S, et al. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain. 2015;156(2):305\u201317.","journal-title":"Pain"},{"key":"850_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2016.04.012","volume":"70","author":"S Comai","year":"2016","unstructured":"Comai S, Bertazzo A, Vachon J, Daigle M, Toupin J, Cote G, et al. Tryptophan via serotonin\/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;70:8\u201316.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"850_CR30","doi-asserted-by":"publisher","first-page":"117864692413124","DOI":"10.1177\/11786469241312475","volume":"18","author":"S Snider","year":"2025","unstructured":"Snider S, Gagliardi F, De Domenico P, Comai S, Bertazzo A, Nasini S, et al. Preoperative peripheral blood serotonin and kynurenine levels are associated with oncological outcomes in glioblastoma IDH-wt patients. Int J Tryptophan Res. 2025;18:11786469241312475.","journal-title":"Int J Tryptophan Res"},{"key":"850_CR31","unstructured":"Paxinos G, Watson C. The rat brain in Stereotaxic Coordinates. In: Stereotaxic coordinates. Academic Press; 2006."},{"issue":"7","key":"850_CR32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo SK, Kwon B. Immune regulation through tryptophan metabolism. Exp Mol Med. 2023;55(7):1371\u201379.","journal-title":"Exp Mol Med"},{"issue":"11","key":"850_CR33","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1172\/JCI43766","volume":"120","author":"MH Ossipov","year":"2010","unstructured":"Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J. Clin. Invest. 2010;120(11):3779\u201387.","journal-title":"J. Clin. Invest"},{"key":"850_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1749-6632.2000.tb06673.x","volume":"909","author":"MH Ossipov","year":"2000","unstructured":"Ossipov MH, Lai J, Malan TP Jr, Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci. 2000;909:12\u201324.","journal-title":"Ann N Y Acad Sci"},{"key":"850_CR35","doi-asserted-by":"publisher","first-page":"963812","DOI":"10.3389\/fnsys.2022.963812","volume":"16","author":"KB McPherson","year":"2022","unstructured":"McPherson KB, Ingram SL. Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway. Front Syst Neurosci. 2022;16:963812.","journal-title":"Front Syst Neurosci"},{"issue":"6","key":"850_CR36","first-page":"667","volume":"12","author":"LP Vera-Portocarrero","year":"2011","unstructured":"Vera-Portocarrero LP, Ossipov MH, Lai J, King T, Porreca F. Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats. J Sport Hist Pain. 2011;12(6):667\u201376.","journal-title":"J Sport Hist Pain"},{"issue":"5","key":"850_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1523\/JNEUROSCI.11-05-01433.1991","volume":"11","author":"H Kaplan","year":"1991","unstructured":"Kaplan H, Fields HL. Hyperalgesia during acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J Neurosci. 1991;11(5):1433\u201339.","journal-title":"J Neurosci"},{"issue":"4","key":"850_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.26599\/BSA.2019.9050025","volume":"5","author":"T Mokhtari","year":"2019","unstructured":"Mokhtari T, Tu Y, Hu L. Involvement of the hippocampus in chronic pain and depression. Brain Sci Adv. 2019;5(4):288\u201398.","journal-title":"Brain Sci Adv"},{"issue":"17","key":"850_CR39","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1523\/JNEUROSCI.0587-12.2012","volume":"32","author":"AA Mutso","year":"2012","unstructured":"Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012;32(17):5747\u201356.","journal-title":"J Neurosci"},{"key":"850_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.brainres.2014.05.025","volume":"1573","author":"A Ezzati","year":"2014","unstructured":"Ezzati A, Zimmerman ME, Katz MJ, Sundermann EE, Smith JL, Lipton ML, et al. Hippocampal subfields differentially correlate with chronic pain in older adults. Brain Res. 2014;1573:54\u201362.","journal-title":"Brain Res"},{"issue":"3","key":"850_CR41","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.087254","volume":"314","author":"KM Raehal","year":"2005","unstructured":"Raehal KM, Walker JK, Bohn LM. Morphine side effects in \u03b2-arrestin 2 knockout mice. J Pharmacol Exp Ther. 2005;314(3):1195\u2013201.","journal-title":"J Pharmacol Exp Ther"},{"key":"850_CR42","doi-asserted-by":"crossref","unstructured":"Bohn LM, Schmid CL. Serotonin receptor signaling and regulation via \u03b2-arrestins. Critical reviews in biochemistry and molecular biology. 2010. 45(6):555\u201366.","DOI":"10.3109\/10409238.2010.516741"},{"issue":"1","key":"850_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2010.10.009","volume":"63","author":"S Comai","year":"2011","unstructured":"Comai S, Cavalletto L, Chemello L, Bernardinello E, Ragazzi E, Costa CV, et al. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C. Pharmacol Res. 2011;63(1):85\u201392.","journal-title":"Pharmacol Res"},{"key":"850_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fphar.2018.00724","volume":"9","author":"E Rojewska","year":"2018","unstructured":"Rojewska E, Ciapa\u0142a K, Piotrowska A, Makuch W, Mika J. Pharmacological inhibition of indoleamine 2, 3-dioxygenase-2 and kynurenine 3-monooxygenase, enzymes of the kynurenine pathway, significantly diminishes neuropathic pain in a rat model. Front Pharmacol. 2018;9:724.","journal-title":"Front Pharmacol"},{"issue":"1","key":"850_CR45","first-page":"104024","volume":"2013","author":"R Lugo-Huitr\u00f3n","year":"2013","unstructured":"Lugo-Huitr\u00f3n R, Ugalde Mu\u00f1iz P, Pineda B, Pedraza-Chaverr\u00ed J, R\u00edos C, P\u00e9rez-de la Cruz V. Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxidative Med Cellular Longevity. 2013;2013(1):104024.","journal-title":"Oxidative Med Cellular Longevity"},{"issue":"20","key":"850_CR46","doi-asserted-by":"publisher","first-page":"11055","DOI":"10.3390\/ijms222011055","volume":"22","author":"K Ciapa\u0142a","year":"2021","unstructured":"Ciapa\u0142a K, Mika J, Rojewska E. The kynurenine pathway as a potential target for neuropathic pain therapy design: from basic research to clinical perspectives. Int J Mol Sci. 2021;22(20):11055.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"850_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/157015912800604515","volume":"10","author":"VM Saito","year":"2012","unstructured":"Saito VM, Rezende RM, Teixeira AL. Cannabinoid modulation of neuroinflammatory disorders. Curr Neuropharmacol. 2012;10(2):159\u201366.","journal-title":"Curr Neuropharmacol"},{"key":"850_CR48","doi-asserted-by":"crossref","unstructured":"Villanueva MRB, Joshaghani N, Villa N, Badla O, Goit R, Saddik SE, et al. Efficacy, safety, and regulation of cannabidiol on chronic pain: a systematic review. Cureus. 2022;14(7).","DOI":"10.7759\/cureus.26913"},{"key":"850_CR49","doi-asserted-by":"crossref","unstructured":"Mohammed SYM, Leis K, Mercado RE, Castillo MMS, Miranda KJ, Carandang RR. Effectiveness of cannabidiol to manage chronic pain: a systematic review. Pain Manag Nurs. 2024;25(2):e76\u201386.","DOI":"10.1016\/j.pmn.2023.10.002"},{"issue":"4","key":"850_CR50","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","volume":"99","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol. Rev. 2019;99(4):2115\u201340.","journal-title":"Physiol. Rev"},{"key":"850_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2023.05.026","volume":"527","author":"J Wang","year":"2023","unstructured":"Wang J, Li Z, Tu Y, Gao F. The dopaminergic System in the ventral tegmental area contributes to morphine analgesia and tolerance. Neuroscience. 2023;527:74\u201383.","journal-title":"Neuroscience"},{"issue":"1","key":"850_CR52","first-page":"6682275","volume":"2021","author":"X-Q Wang","year":"2021","unstructured":"Wang X-Q, Mokhtari T, Zeng Y-X, Yue L-, Hu L. The distinct functions of dopaminergic receptors on pain modulation: a narrative review. Neural Plast. 2021;2021(1):6682275.","journal-title":"Neural Plast"},{"issue":"6","key":"850_CR53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4103\/1673-5374.250567","volume":"14","author":"M Puopolo","year":"2019","unstructured":"Puopolo M. The hypothalamic-spinal dopaminergic system: a target for pain modulation. Neural Regen Res. 2019;14(6):925\u201330.","journal-title":"Neural Regen Res"},{"key":"850_CR54","doi-asserted-by":"crossref","unstructured":"Desch S, Schweinhardt P, Seymour B, Flor H, Becker S. Evidence for dopaminergic involvement in endogenous modulation of pain relief. Elife. 2023;12:e81436.","DOI":"10.7554\/eLife.81436"},{"issue":"8","key":"850_CR55","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/npp.2016.12","volume":"41","author":"C Li","year":"2016","unstructured":"Li C, Sugam JA, Lowery-Gionta EG, McElligott ZA, McCall NM, Lopez AJ, et al. Mu opioid receptor modulation of dopamine neurons in the periaqueductal gray\/dorsal raphe: a role in regulation of pain. Neuropsychopharmacology. 2016;41(8):2122\u201332.","journal-title":"Neuropsychopharmacology"},{"key":"850_CR56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fphar.2019.00295","volume":"10","author":"VB Vel\u00e1squez","year":"2019","unstructured":"Vel\u00e1squez VB, Zamorano GA, Mart\u00ednez-Pinto J, Bonansco C, Jara P, Torres GE, et al. Programming of dopaminergic neurons by early exposure to sex hormones: effects on morphine-induced accumbens dopamine release, reward, and locomotor behavior in male and female rats. Front Pharmacol. 2019;10:295.","journal-title":"Front Pharmacol"},{"issue":"3","key":"850_CR57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/npp.2010.186","volume":"36","author":"NM Urs","year":"2011","unstructured":"Urs NM, Daigle TL, Caron MG. A dopamine D1 receptor-dependent \u03b2-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Neuropsychopharmacology. 2011;36(3):551\u201358.","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"850_CR58","doi-asserted-by":"publisher","first-page":"6708","DOI":"10.3390\/ijms25126708","volume":"25","author":"I Ra\u00efch","year":"2024","unstructured":"Ra\u00efch I, Lillo J, Rivas-Santisteban R, Rebassa JB, Cap\u00f3 T, Santandreu M, et al. Potential of CBD acting on cannabinoid receptors CB1 and CB2 in ischemic stroke. Int J Mol Sci. 2024;25(12):6708.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"850_CR59","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/bcpt.13710","volume":"130","author":"J Peng","year":"2022","unstructured":"Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol. 2022;130(4):439\u201356.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"850_CR60","doi-asserted-by":"publisher","first-page":"989717","DOI":"10.3389\/fphar.2022.989717","volume":"13","author":"S Bhunia","year":"2022","unstructured":"Bhunia S, Kolishetti N, Arias AY, Vashist A, Nair M. Cannabidiol for neurodegenerative disorders: a comprehensive review. Front Pharmacol. 2022;13:989717.","journal-title":"Front Pharmacol"},{"issue":"1","key":"850_CR61","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1038\/s41598-023-34924-z","volume":"13","author":"M Tripson","year":"2023","unstructured":"Tripson M, Litwa K, Soderstrom K. Cannabidiol inhibits neuroinflammatory responses and circuit-associated synaptic loss following damage to a songbird vocal pre-motor cortical-like region. Sci Rep. 2023;13(1):7907.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"850_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","volume":"19","author":"I Lastres-Becker","year":"2005","unstructured":"Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fern\u00e1ndez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson\u2019s disease. Neurobiol Dis. 2005;19(1\u20132):96\u2013107.","journal-title":"Neurobiol Dis"},{"key":"850_CR63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","volume":"1134","author":"M Garc\u00eda-Arencibia","year":"2007","unstructured":"Garc\u00eda-Arencibia M, Gonz\u00e1lez S, de Lago E, Ramos JA, Mechoulam R, Fern\u00e1ndez-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 2007;1134:162\u201370.","journal-title":"Brain Res"},{"key":"850_CR64","doi-asserted-by":"publisher","first-page":"153813","DOI":"10.1016\/j.tox.2024.153813","volume":"505","author":"R Portillo","year":"2024","unstructured":"Portillo R, Abad C, Synova T, Kastner P, Heblik D, Kucera R, et al. Cannabidiol disrupts tryptophan metabolism in the human term placenta. Toxicology. 2024;505:153813.","journal-title":"Toxicology"},{"issue":"8","key":"850_CR65","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3390\/ph3082647","volume":"3","author":"M Jenny","year":"2010","unstructured":"Jenny M, Schr\u00f6cksnadel S, \u00dcberall F, Fuchs D. The potential role of cannabinoids in modulating serotonergic signaling by their influence on tryptophan metabolism. Pharmaceuticals. 2010;3(8):2647\u201360.","journal-title":"Pharmaceuticals"},{"key":"850_CR66","doi-asserted-by":"crossref","unstructured":"Mogil JS, Parisien M, Esfahani SJ, Diatchenko L. Sex differences in mechanisms of pain hypersensitivity. Neurosci Biobehav Rev. 2024;105749.","DOI":"10.1016\/j.neubiorev.2024.105749"},{"issue":"7","key":"850_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41583-020-0310-6","volume":"21","author":"JS Mogil","year":"2020","unstructured":"Mogil JS. Qualitative sex differences in pain processing: emerging evidence of a biased literature. Nat. Rev. Neurosci. 2020;21(7):353\u201365.","journal-title":"Nat. Rev. Neurosci"},{"issue":"5","key":"850_CR68","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00213-021-05995-5","volume":"239","author":"CF Moore","year":"2022","unstructured":"Moore CF, Weerts EM. Cannabinoid tetrad effects of oral \u03b49-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Psychopharmacol (Berl). 2022;239(5):1397\u2013408.","journal-title":"Psychopharmacol (Berl)"},{"key":"850_CR69","doi-asserted-by":"publisher","first-page":"114793","DOI":"10.1016\/j.bbr.2023.114793","volume":"459","author":"ALF Arantes","year":"2024","unstructured":"Arantes ALF, Carvalho MC, Brand\u00e3o ML, Prado WA, de Souza Crippa JA, Lovick TA, et al. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats. Behav Brain Res. 2024;459:114793.","journal-title":"Behav Brain Res"},{"issue":"6","key":"850_CR70","doi-asserted-by":"publisher","first-page":"6010","DOI":"10.3390\/ijms24066010","volume":"24","author":"ML Pais","year":"2023","unstructured":"Pais ML, Martins J, Castelo-Branco M, Goncalves J. Sex differences in tryptophan metabolism: a systematic review focused on neuropsychiatric disorders. Int J Mol Sci. 2023;24(6):6010.","journal-title":"Int J Mol Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00850-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:02:38Z","timestamp":1781686958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00850-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00850-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}